Pharmaceutical

Biocytogen and Myricx Bio partner for development of ADCs

Biocytogen and Myricx Bio have signed an antibody evaluation, option and licence agreement for the development of ADCs.

Sep 9, 2023 - 20:00
Biocytogen and Myricx Bio partner for development of ADCs
Biocytogen and Myricx Bio have signed an antibody evaluation, option and licence agreement for the development of ADCs.
Read the original article

Tags:

Previous Article

EC expands indication approval for Merck’s Ebola vaccine

Next Article

Subcutaneous drugs grant a new lease on life to checkpoint inhibitors

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Sanofi’s $17bn sale of Opella to US investors advances following government deal

Sanofi’s $17bn sale of Opella to US investors advances ...

Oct 22, 2024

Abortion funds run short of money as demand soars and donations fall

Abortion funds run short of money as demand soars and d...

Jan 24, 2024

A research team airs the messy truth about AI in medicine — and gives hospitals a guide to fix it

A research team airs the messy truth about AI in medici...

Apr 27, 2023